查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1888623

全球下一代定序服务市场：市场规模、份额和趋势分析（按服务类型、工作流程、最终用途和地区划分），细分市场预测（2025-2033 年）

Next-generation Sequencing Services Market Size, Share & Trends Analysis Report By Service Type (Human Genome Sequencing, Gene Regulation Services), By Workflow, By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

下一代定序服务市场概览

全球次世代定序服务市场规模预计在2024年达到66.6亿美元，预计到2033年将达到404.3亿美元，2025年至2033年的复合年增长率为22.54%。这一增长是由对先进基因组研究的需求不断增长、遗传疾病患病率上升以及精准医疗的日益普及所驱动的。

遗传性和慢性疾病的盛行率不断上升

下一代定序 (NGS) 服务业需求成长的关键驱动因素之一是全球遗传性疾病和慢性病负担的日益加重。癌症、心血管疾病、神经系统疾病和罕见遗传症候群等疾病的盛行率不断上升，推动了对先进诊断工具的需求。传统诊断方法往往无法识别复杂疾病的潜在遗传病因，而 NGS 可提供全面的基因组讯息，从而实现早期检测和精准诊断。例如，根据美国疾病管制与预防中心 (CDC) 的数据，十分之六的美国人患有至少一种慢性病，十分之四的人同时患有两种或两种以上慢性病。随着世界各地的医疗保健系统向预防性和精准医疗转型，对强大、准确且扩充性的测序服务的需求持续飙升。

由于罕见遗传疾病的复杂性和罕见性，以往诊断难度较大，但如今藉由新一代定序（NGS）技术进行全基因组和EXOME定序，可以有效辨识这些疾病。例如，NGS 可以检测癌症患者的体细胞突变，有助于制定个人化治疗方案，改善患者预后。此外，随着越来越多的人寻求全面的遗传资讯以了解疾病风险并指导医疗决策，临床检查室、医院和研究机构正日益成为专业的 NGS服务供应商。预计在预测期内，随着 NGS 服务逐渐成为全球对抗慢性病和遗传疾病的重要工具，这一趋势将进一步增强。

目录

第一章 分析方法和范围

第二章执行摘要

第三章 市场因素、趋势与范围

  • 市场联动展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场趋势与展望
  • 市场驱动因素
    • 遗传和慢性疾病的趋势日益增长
    • 更加重视品管和安全
  • 市场限制因素分析
    • 实施大规模NGS分析工作流程所面临的挑战
    • 单细胞定序的分析挑战
  • 商业环境分析
    • PESTEL 分析
    • 波特五力分析

第四章 依服务类型进行业务分析

  • 全球次世代定序服务市场按变异分析和服务类型划分
  • 人类基因组定序服务
    • 人类基因体定序服务市场（2021-2033）
  • 单细胞定序服务
    • 单细胞定序服务市场（2021-2033）
  • 微生物基因组定序服务
    • 微生物基因体定序服务市场（2021-2033）
  • 基因调控服务
    • 基因调控服务市场（2021-2033）
    • 小RNA测序服务
    • 晶片测序服务
    • 其他基于基因调控的服务
  • 动植物定序服务
    • 动植物定序服务市场（2021-2033）
  • 其他定序服务
    • 其他定序服务市场（2021-2033 年）

第五章 依工作流程进行业务分析

  • 全球下一代定序服务市场：基于变异分析和工作流程
  • 预测序服务
    • 预测序服务市场（2021-2033）
  • 定序服务
    • 定序服务市场（2021-2033）
  • 数据分析服务
    • 数据分析服务市场（2021-2033）

第六章：依最终用途进行业务分析

  • 全球下一代定序服务市场按变异分析和最终用途划分
  • 大学和其他研究机构
    • 大学及其他研究机构市场（2021-2033 年）
  • 医院和诊所
    • 医院和诊所市场（2021-2033 年）
  • 製药和生物技术机构
    • 医药和生物技术机构市场（2021-2033）
  • 其他的
    • 其他市场（2021-2033 年）

第七章：区域商业分析

  • 下一代定序服务市场：按地区分類的市场份额（2024 年和 2033 年）
  • 北美洲
    • 北美次世代定序服务市场（2021-2033 年）
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 欧洲次世代定序服务市场（2021-2033）
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
    • 瑞士
  • 亚太地区
    • 亚太地区次世代定序服务市场（2021-2033）
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
    • 新加坡
  • 拉丁美洲
    • 拉丁美洲次世代定序服务市场（2021-2033 年）
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 中东和非洲次世代定序服务市场（2021-2033 年）
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争情势

  • 公司分类
  • 策略规划
  • 公司市占率/市场地位分析（2024 年）
  • 公司简介/列表
    • Illumina, Inc.
    • Thermo Fisher Scientific Inc.
    • BGI Genomics
    • Eurofins Genomics
    • GENEWIZ
    • Macrogen Inc.
    • QIAGEN NV
    • Agilent Technologies Inc.
    • Revvity, Inc.
    • Twist Bioscience
Product Code: GVR-2-68038-630-1

Next-generation Sequencing Services Market Summary

The global next-generation sequencing services market size was estimated at USD 6.66 billion in 2024 and is anticipated to reach USD 40.43 billion by 2033, expanding at a CAGR of 22.54% from 2025 to 2033. This growth is driven by the increasing demand for advanced genomic research, the rising prevalence of genetic disorders, and the growing adoption of precision medicine.

Increased Prevalence of Genetic and Chronic Diseases

One of the most significant drivers fueling demand in the next-generation sequencing (NGS) services industry is the rising global burden of genetic and chronic diseases. Conditions such as cancer, cardiovascular diseases, neurological disorders, and rare inherited syndromes are increasing in prevalence, prompting a heightened need for advanced diagnostic tools. Traditional diagnostic methods often fail to identify the underlying genetic causes of complex diseases, whereas NGS offers comprehensive genomic insights that enable early detection and precise diagnosis. For instance, according to data from the Centers for Disease Control and Prevention (CDC), 6 out of 10 Americans suffer from at least one chronic illness. At the same time, 4 out of 10 are affected by two or more chronic conditions. As healthcare systems worldwide shift toward preventive and precision medicine, the demand for robust, accurate, and scalable sequencing services continues to surge.

Rare genetic disorders, often undiagnosed due to their complexity and rarity, can now be effectively identified through whole-genome and exome sequencing provided by NGS services. For example, NGS can detect somatic mutations in cancer patients, facilitating the development of personalized treatment plans and improving patient outcomes. Moreover, as more individuals seek comprehensive genetic information to understand disease risks and inform their healthcare decisions, clinical laboratories, hospitals, and research institutions are increasingly becoming specialized NGS service providers. This trend is expected to intensify during the forecast period, positioning NGS services as an indispensable tool in the global fight against chronic and hereditary diseases.

Global Next-Generation Sequencing Services Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the next-generation sequencing services market on the basis of service type, workflow, end use, and region:

  • Service Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Human Genome Sequencing Services
  • Single Cell Sequencing Services
  • Microbial Genome-based Sequencing Services
  • Gene Regulation Services
    • Small RNA Sequencing
    • ChIP Sequencing
    • Other Gene Regulation-based Services
  • Animal & Plant Sequencing Services
  • Other Sequencing Services
  • Workflow Outlook (Revenue, USD Million, 2021 - 2033)
  • Pre-sequencing
  • Sequencing
  • Data Analysis
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Universities & Other Research Entities
  • Hospitals & Clinics
  • Pharma & Biotech Entities
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
    • Switzerland
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
    • Singapore
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Information analysis
    • 1.2.2. Market formulation & data visualization
    • 1.2.3. Data validation & publishing
  • 1.3. Information Procurement
    • 1.3.1. Primary Others
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Market Model
  • 1.7. Objectives
    • 1.7.1. Objective 1
    • 1.7.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Derivers
    • 3.3.1. Increased Prevalence of Genetic and Chronic Diseases
    • 3.3.2. Rising emphasis on quality control and safety
  • 3.4. Market Restraint Analysis
    • 3.4.1. Challenges pertaining to the implementation of large-scale NGS analysis workflows
    • 3.4.2. Analytical challenges in single-cell sequencing
  • 3.5. Business Environment Analysis
    • 3.5.1. PESTEL Analysis
    • 3.5.2. Porter's Five Forces Analysis

Chapter 4. Service Type Business Analysis

  • 4.1. Global Next-Generation Sequencing Services Market: Service Type Movement Analysis
  • 4.2. Human Genome Sequencing Services
    • 4.2.1. Human Genome Sequencing Services Market, 2021 - 2033 (USD Million)
  • 4.3. Single-Cell Sequencing Services
    • 4.3.1. Single-Cell Sequencing Services Market, 2021 - 2033 (USD Million)
  • 4.4. Microbial Genome-based Sequencing Services
    • 4.4.1. Microbial Genome-based Sequencing Services Market, 2021 - 2033 (USD Million)
  • 4.5. Gene Regulation Services
    • 4.5.1. Gene Regulation Services Market, 2021 - 2033 (USD Million)
    • 4.5.2. Small RNA Sequencing Services
      • 4.5.2.1. Small RNA Sequencing Services Market, 2021 - 2033 (USD Million)
    • 4.5.3. Chip Sequencing Services
      • 4.5.3.1. Chip Sequencing Services Market, 2021 - 2033 (USD Million)
    • 4.5.4. Other Gene Regulation-based Service
      • 4.5.4.1. Other Gene Regulation-based Service Market, 2021 - 2033 (USD Million)
  • 4.6. Animal & Plant Sequencing Services
    • 4.6.1. Animal & Plant Sequencing Services Market, 2021 - 2033 (USD Million)
  • 4.7. Other Sequencing Services
    • 4.7.1. Other Sequencing Services Market, 2021 - 2033 (USD Million)

Chapter 5. Workflow Business Analysis

  • 5.1. Global Next-Generation Sequencing Services Market: Workflow Movement Analysis
  • 5.2. Pre Sequencing Service
    • 5.2.1. Pre Sequencing Service Market, 2021 - 2033 (USD Million)
  • 5.3. Sequencing Service
    • 5.3.1. Sequencing Service Market, 2021 - 2033 (USD Million)
  • 5.4. Data Analysis Service
    • 5.4.1. Data Analysis Service Market, 2021 - 2033 (USD Million)

Chapter 6. End Use Business Analysis

  • 6.1. Global Next-Generation Sequencing Services Market: End Use Movement Analysis
  • 6.2. Universities & Other Research Entities
    • 6.2.1. Universities & Other Research Entities Market, 2021 - 2033 (USD Million)
  • 6.3. Hospitals & Clinics
    • 6.3.1. Hospitals & Clinics Market, 2021 - 2033 (USD Million)
  • 6.4. Pharma & Biotech Entities
    • 6.4.1. Pharma & Biotech Entities Market, 2021 - 2033 (USD Million)
  • 6.5. Others
    • 6.5.1. Others Market, 2021 - 2033 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Global Next-Generation Sequencing Services Market Share, By Region, 2024 & 2033
  • 7.2. North America
    • 7.2.1. North America Next-generation sequencing services market, 2021 - 2033 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. Key Country Dynamics
      • 7.2.2.2. Competitive Scenario
      • 7.2.2.3. Regulatory Framework
      • 7.2.2.4. Target Disease Prevalence
      • 7.2.2.5. U.S. Next-generation sequencing services market, 2021 - 2033 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Competitive Scenario
      • 7.2.3.3. Regulatory Framework
      • 7.2.3.4. Target Disease Prevalence
      • 7.2.3.5. Canada Next-generation sequencing services market, 2021 - 2033 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Key Country Dynamics
      • 7.2.4.2. Competitive Scenario
      • 7.2.4.3. Regulatory Framework
      • 7.2.4.4. Target Disease Prevalence
      • 7.2.4.5. Mexico Next-generation sequencing services market, 2021 - 2033 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Next-generation sequencing services market, 2021 - 2033 (USD Million)
    • 7.3.2. Germany
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. Target Disease Prevalence
      • 7.3.2.5. Germany Next-generation sequencing services market, 2021 - 2033 (USD Million)
    • 7.3.3. UK
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Target Disease Prevalence
      • 7.3.3.5. UK Next-generation sequencing services market, 2021 - 2033 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. Target Disease Prevalence
      • 7.3.4.5. France Next-generation sequencing services market, 2021 - 2033 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Competitive Scenario
      • 7.3.5.3. Regulatory Framework
      • 7.3.5.4. Target Disease Prevalence
      • 7.3.5.5. Italy Next-generation sequencing services market, 2021 - 2033 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Competitive Scenario
      • 7.3.6.3. Regulatory Framework
      • 7.3.6.4. Target Disease Prevalence
      • 7.3.6.5. Spain Next-generation sequencing services market, 2021 - 2033 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Competitive Scenario
      • 7.3.7.3. Regulatory Framework
      • 7.3.7.4. Target Disease Prevalence
      • 7.3.7.5. Denmark Next-generation sequencing services market, 2021 - 2033 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Competitive Scenario
      • 7.3.8.3. Regulatory Framework
      • 7.3.8.4. Target Disease Prevalence
      • 7.3.8.5. Sweden Next-generation sequencing services market, 2021 - 2033 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Competitive Scenario
      • 7.3.9.3. Regulatory Framework
      • 7.3.9.4. Target Disease Prevalence
      • 7.3.9.5. Norway Next-generation sequencing services market, 2021 - 2033 (USD Million)
    • 7.3.10. Switzerland
      • 7.3.10.1. Key Country Dynamics
      • 7.3.10.2. Competitive Scenario
      • 7.3.10.3. Regulatory Framework
      • 7.3.10.4. Target Disease Prevalence
      • 7.3.10.5. Switzerland Next-generation sequencing services market, 2021 - 2033 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Next-generation sequencing services market, 2021 - 2033 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Target Disease Prevalence
      • 7.4.2.5. Japan Next-generation sequencing services market, 2021 - 2033 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Target Disease Prevalence
      • 7.4.3.5. China Next-generation sequencing services market, 2021 - 2033 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. Target Disease Prevalence
      • 7.4.4.5. India Next-generation sequencing services market, 2021 - 2033 (USD Million)
    • 7.4.5. South Korea
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Target Disease Prevalence
      • 7.4.5.5. South Korea Next-generation sequencing services market, 2021 - 2033 (USD Million)
    • 7.4.6. Australia
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Target Disease Prevalence
      • 7.4.6.5. Australia Next-generation sequencing services market, 2021 - 2033 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. Target Disease Prevalence
      • 7.4.7.5. Thailand Next-generation sequencing services market, 2021 - 2033 (USD Million)
    • 7.4.8. Singapore
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Competitive Scenario
      • 7.4.8.3. Regulatory Framework
      • 7.4.8.4. Target Disease Prevalence
      • 7.4.8.5. Singapore Next-generation sequencing services market, 2021 - 2033 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Next-generation sequencing services market, 2021 - 2033 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Target Disease Prevalence
      • 7.5.2.5. Brazil Next-generation sequencing services market, 2021 - 2033 (USD Million)
    • 7.5.3. Argentina
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Target Disease Prevalence
      • 7.5.3.5. Argentina Next-generation sequencing services market, 2021 - 2033 (USD Million)
  • 7.6. MEA
    • 7.6.1. MEA Next-generation sequencing services market, 2021 - 2033 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Target Disease Prevalence
      • 7.6.2.5. South Africa Next-generation sequencing services market, 2021 - 2033 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Target Disease Prevalence
      • 7.6.3.5. Saudi Arabia Next-generation sequencing services market, 2021 - 2033 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Target Disease Prevalence
      • 7.6.4.5. UAE Next-generation sequencing services market, 2021 - 2033 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Target Disease Prevalence
      • 7.6.5.5. Kuwait Next-generation sequencing services market, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market/Position Share Analysis, 2024
  • 8.4. Company Profiles/Listing
    • 8.4.1. Illumina, Inc.
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Thermo Fisher Scientific Inc.
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. BGI Genomics
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Eurofins Genomics
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. GENEWIZ
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Macrogen Inc.
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. QIAGEN N.V.
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. Agilent Technologies Inc.
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Revvity, Inc.
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. Twist Bioscience
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List Of Secondary Sources
  • Table 2 List Of Abbreviations
  • Table 3 Global next-generation sequencing services market by service type, 2021 - 2033 (USD million)
  • Table 4 Global next-generation sequencing services market by workflow, 2021 - 2033 (USD million)
  • Table 5 Global next-generation sequencing services market by end use, 2021 - 2033 (USD million)
  • Table 6 North America next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2021 - 2033 (USD Million)
  • Table 7 North America next-generation sequencing services market estimates & forecasts, by workflow, 2021 - 2033 (USD Million)
  • Table 8 North America next-generation sequencing services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 9 North America next-generation sequencing services market estimates & forecasts, by country, 2021 - 2033 (USD Million)
  • Table 10 U.S. next-generation sequencing services market estimates & forecasts, by service type, 2021 - 2033 (USD Million)
  • Table 11 U.S. next-generation sequencing services market estimates & forecasts, by workflow, 2021 - 2033 (USD Million)
  • Table 12 U.S. next-generation sequencing services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 13 Canada next-generation sequencing services market estimates & forecasts, by service type, 2021 - 2033 (USD Million)
  • Table 14 Canada next-generation sequencing services market estimates & forecasts, by workflow, 2021 - 2033 (USD Million)
  • Table 15 Canada next-generation sequencing services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 16 Mexico next-generation sequencing services market estimates & forecasts, by service type, 2021 - 2033 (USD Million)
  • Table 17 Mexico next-generation sequencing services market estimates & forecasts, by workflow, 2021 - 2033 (USD Million)
  • Table 18 Mexico next-generation sequencing services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 19 Europe next-generation sequencing services market estimates & forecasts, by service type, 2021 - 2033 (USD Million)
  • Table 20 Europe next-generation sequencing services market estimates & forecasts, by workflow, 2021 - 2033 (USD Million)
  • Table 21 Europe next-generation sequencing services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 22 Europe next-generation sequencing services market estimates & forecasts, by country, 2021 - 2033 (USD Million)
  • Table 23 Germany next-generation sequencing services market estimates & forecasts, by service type, 2021 - 2033 (USD Million)
  • Table 24 Germany next-generation sequencing services market estimates & forecasts, by workflow, 2021 - 2033 (USD Million)
  • Table 25 Germany next-generation sequencing services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 26 UK next-generation sequencing services market estimates & forecasts, by service type, 2021 - 2033 (USD Million)
  • Table 27 UK next-generation sequencing services market estimates & forecasts, by workflow, 2021 - 2033 (USD Million)
  • Table 28 UK next-generation sequencing services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 29 France next-generation sequencing services market estimates & forecasts, by service type, 2021 - 2033 (USD Million)
  • Table 30 France next-generation sequencing services market estimates & forecasts, by workflow, 2021 - 2033 (USD Million)
  • Table 31 France next-generation sequencing services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 32 Italy next-generation sequencing services market estimates & forecasts, by service type, 2021 - 2033 (USD Million)
  • Table 33 Italy next-generation sequencing services market estimates & forecasts, by workflow, 2021 - 2033 (USD Million)
  • Table 34 Italy next-generation sequencing services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 35 Spain next-generation sequencing services market estimates & forecasts, by service type, 2021 - 2033 (USD Million)
  • Table 36 Spain next-generation sequencing services market estimates & forecasts, by workflow, 2021 - 2033 (USD Million)
  • Table 37 Spain next-generation sequencing services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 38 Denmark next-generation sequencing services market estimates & forecasts, by service type, 2021 - 2033 (USD Million)
  • Table 39 Denmark next-generation sequencing services market estimates & forecasts, by workflow, 2021 - 2033 (USD Million)
  • Table 40 Denmark next-generation sequencing services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 41 Sweden next-generation sequencing services market estimates & forecasts, by service type, 2021 - 2033 (USD Million)
  • Table 42 Sweden next-generation sequencing services market estimates & forecasts, by workflow, 2021 - 2033 (USD Million)
  • Table 43 Sweden next-generation sequencing services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 44 Norway next-generation sequencing services market estimates & forecasts, by service type, 2021 - 2033 (USD Million)
  • Table 45 Norway next-generation sequencing services market estimates & forecasts, by workflow, 2021 - 2033 (USD Million)
  • Table 46 Norway next-generation sequencing services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 47 Switzerland next-generation sequencing services market estimates & forecasts, by service type, 2021 - 2033 (USD Million)
  • Table 48 Switzerland next-generation sequencing services market estimates & forecasts, by workflow, 2021 - 2033 (USD Million)
  • Table 49 Switzerland next-generation sequencing services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific next-generation sequencing services market estimates & forecasts, by service type, 2021 - 2033 (USD Million)
  • Table 51 Asia Pacific next-generation sequencing services market estimates & forecasts, by workflow, 2021 - 2033 (USD Million)
  • Table 52 Asia Pacific next-generation sequencing services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 53 Asia Pacific next-generation sequencing services market estimates & forecasts, by country, 2021 - 2033 (USD Million)
  • Table 54 Japan next-generation sequencing services market estimates & forecasts, by service type, 2021 - 2033 (USD Million)
  • Table 55 Japan next-generation sequencing services market estimates & forecasts, by workflow, 2021 - 2033 (USD Million)
  • Table 56 Japan next-generation sequencing services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 57 China next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2021 - 2033 (USD Million)
  • Table 58 China next-generation sequencing services market estimates & forecasts, by workflow, 2021 - 2033 (USD Million)
  • Table 59 China next-generation sequencing services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 60 India next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2021 - 2033 (USD Million)
  • Table 61 India next-generation sequencing services market estimates & forecasts, by workflow, 2021 - 2033 (USD Million)
  • Table 62 India next-generation sequencing services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 63 Australia next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2021 - 2033 (USD Million)
  • Table 64 Australia next-generation sequencing services market estimates & forecasts, by workflow, 2021 - 2033 (USD Million)
  • Table 65 Australia next-generation sequencing services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 66 South Korea next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2021 - 2033 (USD Million)
  • Table 67 South Korea next-generation sequencing services market estimates & forecasts, by workflow, 2021 - 2033 (USD Million)
  • Table 68 South Korea next-generation sequencing services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 69 Thailand next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2021 - 2033 (USD Million)
  • Table 70 Thailand next-generation sequencing services market estimates & forecasts, by workflow, 2021 - 2033 (USD Million)
  • Table 71 Thailand next-generation sequencing services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 72 Singapore next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2021 - 2033 (USD Million)
  • Table 73 Singapore next-generation sequencing services market estimates & forecasts, by workflow, 2021 - 2033 (USD Million)
  • Table 74 Singapore next-generation sequencing services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 75 Latin America next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2021 - 2033 (USD Million)
  • Table 76 Latin America next-generation sequencing services market estimates & forecasts, by workflow, 2021 - 2033 (USD Million)
  • Table 77 Latin America next-generation sequencing services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 78 Latin America next-generation sequencing services market estimates & forecasts, by country, 2021 - 2033 (USD Million)
  • Table 79 Brazil next-generation sequencing services market estimates & forecasts, by service type, 2021 - 2033 (USD Million)
  • Table 80 Brazil next-generation sequencing services market estimates & forecasts, by workflow, 2021 - 2033 (USD Million)
  • Table 81 Brazil next-generation sequencing services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 82 Argentina next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2021 - 2033 (USD Million)
  • Table 83 Argentina next-generation sequencing services market estimates & forecasts, by workflow, 2021 - 2033 (USD Million)
  • Table 84 Argentina next-generation sequencing services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 85 MEA next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2021 - 2033 (USD Million)
  • Table 86 MEA next-generation sequencing services market estimates & forecasts, by workflow, 2021 - 2033 (USD Million)
  • Table 87 MEA next-generation sequencing services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 88 MEA next-generation sequencing services market estimates & forecasts, by country, 2021 - 2033 (USD Million)
  • Table 89 South Africa next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2021 - 2033 (USD Million)
  • Table 90 South Africa next-generation sequencing services market estimates & forecasts, by workflow, 2021 - 2033 (USD Million)
  • Table 91 South Africa next-generation sequencing services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 92 Saudi Arabia next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2021 - 2033 (USD Million)
  • Table 93 Saudi Arabia next-generation sequencing services market estimates & forecasts, by workflow, 2021 - 2033 (USD Million)
  • Table 94 Saudi Arabia next-generation sequencing services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 95 UAE next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2021 - 2033 (USD Million)
  • Table 96 UAE next-generation sequencing services market estimates & forecasts, by workflow, 2021 - 2033 (USD Million)
  • Table 97 UAE next-generation sequencing services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 98 Kuwait next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2021 - 2033 (USD Million)
  • Table 99 Kuwait next-generation sequencing services market estimates & forecasts, by workflow, 2021 - 2033 (USD Million)
  • Table 100 Kuwait next-generation sequencing services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 101 Participant's Overview

List of Figures

  • Fig. 1 Market Others process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary Others pattern
  • Fig. 4 Market Others approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market summary, 2024 (USD Million)
  • Fig. 9 Market segmentation & scope
  • Fig. 10 Market driver impact
  • Fig. 11 Market restraint impact
  • Fig. 12 Penetration & growth prospect mapping
  • Fig. 13 Porter's analysis
  • Fig. 14 SWOT analysis
  • Fig. 15 Next-generation sequencing services market: Service type outlook and key takeaways
  • Fig. 16 Next-generation sequencing services market: Service type movement analysis
  • Fig. 17 Human genome sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 18 Single-cell sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 19 Microbial genome-based sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 20 Gene regulation services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 21 Small RNA sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 22 Chip sequencing service market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 23 Other gene regulation-based service market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 24 Animal & plant sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 25 Other sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 26 Next-generation sequencing services market: Workflow outlook and key takeaways
  • Fig. 27 Next-generation sequencing services market: Workflow movement analysis
  • Fig. 28 Pre-sequenceing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 29 Sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 30 Data analysis service market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 31 Next-generation sequencing services market: End use outlook and key takeaways
  • Fig. 32 Next-generation sequencing services market: End use movement analysis
  • Fig. 33 Universities & other research entities, 2021 - 2033 (USD Million)
  • Fig. 34 Hospitals & clinics, 2021 - 2033 (USD Million)
  • Fig. 35 Pharma & biotech entities, 2021 - 2033 (USD Million)
  • Fig. 36 Other end use, 2021 - 2033 (USD Million)
  • Fig. 37 Global next-generation sequencing services market: Regional outlook and key takeaways
  • Fig. 38 North America next-generation sequencing services market, 2021 - 2033 (USD Million)
  • Fig. 39 U.S. key country dynamics
  • Fig. 40 U.S. next-generation sequencing services market, 2021 - 2033 (USD Million)
  • Fig. 41 Canada key country dynamics
  • Fig. 42 Canada next-generation sequencing services market, 2021 - 2033 (USD Million)
  • Fig. 43 Mexico key country dynamics
  • Fig. 44 Mexico next-generation sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 45 Europe next-generation sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 46 Germany key country dynamics
  • Fig. 47 Germany next-generation sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 48 France key country dynamics
  • Fig. 49 France next-generation sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 50 UK key country dynamics
  • Fig. 51 UK next-generation sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 52 Italy key country dynamics
  • Fig. 53 Italy next-generation sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 54 Spain key country dynamics
  • Fig. 55 Spain next-generation sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 56 Denmark key country dynamics
  • Fig. 57 Denmark next-generation sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 58 Sweden key country dynamics
  • Fig. 59 Sweden next-generation sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 60 Norway key country dynamics
  • Fig. 61 Norway next-generation sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 62 Switzerland key country dynamics
  • Fig. 63 Switzerland next-generation sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 64 Asia-Pacific next-generation sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 65 China key country dynamics
  • Fig. 66 China next-generation sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 67 India key country dynamics
  • Fig. 68 India next-generation sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 69 South Korea key country dynamics
  • Fig. 70 South Korea next-generation sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 71 Japan key country dynamics
  • Fig. 72 Japan next-generation sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 73 Australia key country dynamics
  • Fig. 74 Australia next-generation sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 75 Thailand key country dynamics
  • Fig. 76 Thailand next-generation sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 77 Singapore key country dynamics
  • Fig. 78 Singapore next-generation sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 79 Latin America next-generation sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 80 Brazil key country dynamics
  • Fig. 81 Brazil next-generation sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 82 Argentina key country dynamics
  • Fig. 83 Argentina next-generation sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 84 MEA next-generation sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 85 South Africa key country dynamics
  • Fig. 86 South Africa next-generation sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 87 Saudi Arabia key country dynamics
  • Fig. 88 Saudi Arabia next-generation sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 89 UAE key country dynamics
  • Fig. 90 UAE next-generation sequencing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 91 Kuwait key country dynamics
  • Fig. 92 Kuwait next-generation sequencing services market estimates and forecast, 2021 - 2033 (USD Million)